Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer her insights on the key market trends impacting the emerging field of precision medicine and shares her outlook on the future of genomic sequencing.
By using AI, big data, and other technologies we can explore how to translate the findings of NGS into usable information and knowledge at a much faster pace than ever before
